MDXG
Mimedx Group, Inc.Company with tickers: MDXG
CIK
1376339
CUSIP
602496101
Shares Outstanding
148,945,731
13F Activity (30d)
195 filings
192 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $88,205,000 | USD | 2025-03-31 | 10-Q | 2026-04-29 |
| Cost of Revenue | — | ||||
| Gross Profit | $71,647,000 | USD | 2025-03-31 | 10-Q | 2026-04-29 |
| Operating Expenses | — | ||||
| Research & Development | $3,328,000 | USD | 2025-03-31 | 10-Q | 2026-04-29 |
| Operating Income | $8,251,000 | USD | 2025-03-31 | 10-Q | 2026-04-29 |
| Net Income | $7,023,000 | USD | 2025-03-31 | 10-Q | 2026-04-29 |
| EPS (Basic) | $0.05 | USD/shares | 2025-03-31 | 10-Q | 2026-04-29 |
| EPS (Diluted) | $0.05 | USD/shares | 2025-03-31 | 10-Q | 2026-04-29 |